drugset / Trial / NCT07818564

Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation

NCT07818564 ↗

Phase 1 Recruiting 24 enrolled Brown University
RandomizedParallel-groupTriple-blindBasic science

Summary

The primary aim of this phase I mechanistic pilot study is to evaluate the effects of psilocybin on aspects of cognition in healthy adult volunteers. Up to 24 participants will receive a single dose of either psilocybin or inert placebo, and they will be asked to complete several computer-based behavioral tasks measuring features of learning, belief updating, and abstraction. Participants will also complete measures of subjective experience and expectancy, as well as semi-structured interviews at follow up, to assess whether experience correlates with behavior. This is a Voluntary Submission.

Timeline

Start
2026-11
Primary completion
2027-11
Completion
2027-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 25 mg Oral

Indications

No indication recorded.